Publication Name	World Journal of Gastroenterology
Manuscript ID	88713
Country	China

Received	2023-10-06 17:23
Peer-Review Started	2023-10-06 17:26
To Make the First Decision
Return for Revision	2023-12-06 06:14
Revised	2023-12-12 17:45
Second Decision	2024-01-04 02:49
Accepted by Journal Editor-in-Chief
Accepted by Company Editor-in-Chief	2024-01-04 06:11
Articles in Press	2024-01-04 06:11
Publication Fee Transferred
Edit the Manuscript by Language Editor
Typeset the Manuscript	2024-01-05 01:10
Publish the Manuscript Online	2024-01-18 09:58

ISSN	1007-9327 (print) and 2219-2840 (online)
Open Access	This article is an open-access article that was selected by an in-house editor and fully peer-reviewed by external reviewers. It is distributed in accordance with the Creative Commons Attribution NonCommercial (CC BY-NC 4.0) license, which permits others to distribute, remix, adapt, build upon this work non-commercially, and license their derivative works on different terms, provided the original work is properly cited and the use is non-commercial. See: https://creativecommons.org/Licenses/by-nc/4.0/
Copyright	© The Author(s) 2024. Published by Baishideng Publishing Group Inc. All rights reserved.
Article Reprints	For details, please visit: http://www.wjgnet.com/bpg/gerinfo/247
Permissions	For details, please visit: http://www.wjgnet.com/bpg/gerinfo/207
Publisher	Baishideng Publishing Group Inc, 7041 Koll Center Parkway, Suite 160, Pleasanton, CA 94566, USA
Website	http://www.wjgnet.com

Category	Medicine, Research & Experimental
Manuscript Type	Letter to the Editor
Article Title	Use of curcumin and its nanopreparations in the treatment of inflammatory bowel disease
Manuscript Source	Unsolicited Manuscript
All Author List	Zi-Wen Meng, Bing Chang and Li-Xuan Sang
ORCID	Author(s) ORCID Number Zi-Wen Meng http://orcid.org/0009-0001-8268-3698 Bing Chang http://orcid.org/0000-0003-1965-5827 Li-Xuan Sang http://orcid.org/0000-0002-4562-0022
Funding Agency and Grant Number
Corresponding Author	Li-Xuan Sang, MD, PhD, Professor, Department of Gastroenterology, Shengjing Hospital of China Medical University, No. 39 Gliding Road, Tiexi District, Shenyang 110022, Liaoning Province, China. sanglixuan2008@163.com
Key Words	Curcumin; Inflammatory bowel disease; Bioavailability; Nanotherapeutics; Nuclear factor-κB pathway; C-Jun amino-terminal kinases; Extracellular-signal-regulated kinases; Stress-activated protein kinases
Core Tip	Curcumin (CUR) can efficiently decrease the activity of proinflammatory cytokines by communicating with transcription factors and signaling molecules. It is a new area of research that may be promising in the future to treat patients with inflammatory bowel disease, especially in patients with ulcerative colitis. How to improve the bioavailability of CUR in vivo was also discussed.
Publish Date	2024-01-18 09:58
Citation	Meng ZW, Chang B, Sang LX. Use of curcumin and its nanopreparations in the treatment of inflammatory bowel disease. World J Gastroenterol 2024; 30(3): 280-282
URL	https://www.wjgnet.com/1007-9327/full/v30/i3/280.htm
DOI	https://dx.doi.org/10.3748/wjg.v30.i3.280

Full Article (PDF)	WJG-30-280-with-cover.pdf
Full Article (Word)	WJG-30-280.docx
Manuscript File	88713_Auto_Edited-YJP.docx
Answering Reviewers	88713-Answering reviewers.pdf
Audio Core Tip	88713-Audio core tip.m4a
Conflict-of-Interest Disclosure Form	88713-Conflict-of-interest statement.pdf
Copyright License Agreement	88713-Copyright license agreement.pdf
Non-Native Speakers of English Editing Certificate	88713-Language certificate.pdf
Peer-review Report	88713-Peer-review(s).pdf
Scientific Misconduct Check	88713-Bing-Qu XL-2.png
Scientific Editor Work List	88713-Scientific editor work list.pdf